Astute Capital launches Astute Anomaly Fund
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
GPN Vaccines raises AU$ 7 million in oversubscribed funding
30 Jun 2020 GPN Vaccines closes A$7 million Series A2 round oversubscribed with Forepont Capital Partners becoming a significant investor Adelaide, Australia, 30th June 2020 – Australian biotechnology company GPN Vaccines, which is developing a vaccine against the world’s foremost bacterial pathogen, Streptococcus pneumoniae, is pleased to announce it has raised A$7 million
Astute Ventures invests in GPN Vaccines
1 Jun 2020 Astute Ventures makes an investment in Australia based GPN Vaccines Pty Ltd. Reasons for the investment GPN Vaccine covers all 100 Serotypes (strains) of Pneumonia and all future Serotypes. Pneumonia is a common respiratory infection, affecting approximately 450 million people a year and occurring in all parts of the world. It
Astute Capital launches Astute Ventures
1 Jun 2020 Astute Capital launches Astute Ventures LLC
Nullam neque sapien pharetra
Fusce nec erat sed nisl lobortis eleifend. In eu fringilla leo. Curabitur dignissim efficitur lorem nec fermentum. Etiam laoreet est facilisis consequat aliquam. Nullam sollicitudin pulvinar arcu, porttitor dictum orci luctus sagittis. Fusce vestibulum nibh augue, ut luctus urna feugiat eu. Mauris aliquet dictum sem, vel pellentesque nisi cursus eget. "Quisque
Aliquam congue semper metus
Aliquam commodo nulla ligula. Curabitur ut nunc id nisl scelerisque egestas. Nulla vulputate mauris eget nisl rhoncus viverra vel eu mi. Integer iaculis tortor eget lectus laoreet congue. Pellentesque eget convallis leo. Proin porttitor tincidunt eros. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. "Quisque eleifend
Vivamus ut magna turpis
Pellentesque a massa nec massa laoreet iaculis. Nam fermentum porta velit. Aenean mattis bibendum dictum. Nulla convallis egestas risus. Curabitur a nisi in urna rutrum euismod at eget arcu. Nam turpis justo, luctus a pulvinar quis, interdum aliquet elit. Nullam faucibus lectus et erat auctor, ac commodo nulla cursus. Praesent imperdiet luctus magna.
Aliquam luctus sem massa
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus quis lorem pellentesque massa placerat vestibulum eu nec quam. Nulla semper in elit a varius. Nullam in fermentum massa. In hac habitasse platea dictumst. In quis magna quis ex accumsan maximus. In vitae orci scelerisque, congue velit sed, imperdiet velit. "Quisque eleifend
Aenean consectetur tempor metus, eget ut sapien
Nunc dignissim sagittis laoreet. Phasellus sem odio, dignissim quis tortor vel, mollis egestas nulla. In quis malesuada magna. Donec lobortis urna eros, tincidunt sagittis tortor venenatis vitae. Sed lacinia elit sit amet massa tempor, euismod efficitur ex dictum. Nullam scelerisque nibh dolor, nec ultricies libero rhoncus id. Ut sodales ligula ac purus vulputate.
Sed placerat velit ante feugiat
Quisque in lacus egestas, aliquet velit id, congue velit. Pellentesque ullamcorper laoreet risus, a rutrum erat aliquet eget. In dictum nulla et enim auctor, vitae dictum velit lobortis. Sed vitae tortor quis enim placerat efficitur in id urna. In in pretium metus, malesuada mattis elit. Phasellus lobortis risus a est ultrices convallis.